Stem cells in retinal regeneration: Past, present and future

Development (Cambridge)

Volumn 140, Issue 12, 2013, Pages 2576-2585

  Ramsden, Conor M ^a,b   Powner, Michael B ^a   Carr, Amanda Jayne F ^a   Smart, Matthew J K ^a   da Cruz, Lyndon ^a,b   Coffey, Peter J ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Age related macular degeneration; Clinical trials; Retinitis pigmentosa; Stargardt's disease; Stem cells

Indexed keywords

DIABETIC RETINOPATHY; EMBRYONIC STEM CELL; FETAL STEM CELL; HUMAN; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; REGENERATION; RETINA DISEASE; RETINA MACULA AGE RELATED DEGENERATION; RETINAL REGENERATION; RETINITIS PIGMENTOSA; REVIEW; STARGARDT DISEASE; STEM CELL TRANSPLANTATION;

A GE-RELATED MACULAR DEGENERATION; CLINICAL TRIALS; RETINITIS PIGMENTOSA; STARGARDT'S DISEASE; STEM CELLS;

ANIMALS; BONE MARROW; CLINICAL TRIALS AS TOPIC; EMBRYONIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MACULAR DEGENERATION; PHOTORECEPTOR CELLS, VERTEBRATE; RATS; REGENERATION; RETINA; RETINAL PIGMENT EPITHELIUM; RETINITIS PIGMENTOSA; STEM CELL TRANSPLANTATION;

EID: 84878388504     PISSN: 09501991     EISSN: 14779129     Source Type: Journal    
DOI: 10.1242/dev.092270     Document Type: Review

References (86)

1. Age-Related Eye Disease Study Research Group (2001). A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch. Ophthalmol. 119, 1417-1436.
2. Allikmets, R., Singh, N., Sun, H., Shroyer, N. F., Hutchinson, A., Chidambaram, A., Gerrard, B., Baird, L., Stauffer, D., Peiffer, A. et al. (1997). A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat. Genet. 15, 236-246.
3. Araki, R., Uda, M., Hoki, Y., Sunayama, M., Nakamura, M., Ando, S., Sugiura, M., Ideno, H., Shimada, A., Nifuji, A. et al. (2013). Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells. Nature 494, 100-104.
4. Arnhold, S., Klein, H., Semkova, I., Addicks, K. and Schraermeyer, U. (2004). Neurally selected embryonic stem cells induce tumor formation after longterm survival following engraftment into the subretinal space. Invest. Ophthalmol. Vis. Sci. 45, 4251-4255.
5. Arnhold, S., Absenger, Y., Klein, H., Addicks, K. and Schraermeyer, U. (2007). Transplantation of bone marrow-derived mesenchymal stem cells rescue photoreceptor cells in the dystrophic retina of the rhodopsin knockout mouse. Graefe's Arch. Clin. Exp. Ophthalmol. 245, 414-422.
6. Atmaca-Sonmez, P., Li, Y., Yamauchi, Y., Schanie, C. L., Ildstad, S. T., Kaplan, H. J. and Enzmann, V. (2006). Systemically transferred hematopoietic stem cells home to the subretinal space and express RPE-65 in a mouse model of retinal pigment epithelium damage. Exp. Eye Res. 83, 1295-1302.
7. Baglio, S. R., Pegtel, D. M. and Baldini, N. (2012). Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy. Front. Physiol. 3, 359.
8. Banin, E., Obolensky, A., Idelson, M., Hemo, I., Reinhardtz, E., Pikarsky, E., Ben-Hur, T. and Reubinoff, B. (2006). Retinal incorporation and differentiation of neural precursors derived from human embryonic stem cells. Stem Cells 24, 246-257.
9. Binder, S., Stanzel, B. V., Krebs, I. and Glittenberg, C. (2007). Transplantation of the RPE in AMD. Prog. Retin. Eye Res. 26, 516-554.
10. Buchholz, D. E., Hikita, S. T., Rowland, T. J., Friedrich, A. M., Hinman, C. R., Johnson, L. V. and Clegg, D. O. (2009). Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Stem Cells 27, 2427-2434.
11. Carr, A.-J., Vugler, A. A., Hikita, S. T., Lawrence, J. M., Gias, C., Chen, L. L., Buchholz, D. E., Ahmado, A., Semo, M., Smart, M. J. K. et al. (2009). Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. PLoS ONE 4, e8152.
12. Carr, A.-J. F., Smart, M. J. K., Ramsden, C. M., Powner, M. B., da Cruz, L. and Coffey, P. J. (2013). Development of human embryonic stem cell therapies for age-related macular degeneration. Trends Neurosci. doi: 10.1016/j.tins.2013.03.006.
13. Chen, F. K., Uppal, G. S., MacLaren, R. E., Coffey, P. J., Rubin, G. S., Tufail, A., Aylward, G. W. and Da Cruz, L. (2009). Long-term visual and microperimetry outcomes following autologous retinal pigment epithelium choroid graft for neovascular age-related macular degeneration. Clin. Experiment. Ophthalmol. 37, 275-285.
14. Churchill, A. J., Carter, J. G., Lovell, H. C., Ramsden, C., Turner, S. J., Yeung, A., Escardo, J. and Atan, D. (2006). VEGF polymorphisms are associated with neovascular age-related macular degeneration. Hum. Mol. Genet. 15, 2955-2961.
15. D'Cruz, P. M., Yasumura, D., Weir, J., Matthes, M. T., Abderrahim, H., LaVail, M. M. and Vollrath, D. (2000). Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS rat. Hum. Mol. Genet. 9, 645-651.
16. da Cruz, L., Chen, F. K., Ahmado, A., Greenwood, J. and Coffey, P. (2007). RPE transplantation and its role in retinal disease. Prog. Retin. Eye Res. 26, 598-635.
17. de Jong, P. T. V. M. (2006). Age-related macular degeneration. N. Engl. J. Med. 355, 1474-1485.
18. Doi, A., Park, I.-H., Wen, B., Murakami, P., Aryee, M. J., Irizarry, R., Herb, B., Ladd-Acosta, C., Rho, J., Loewer, S. et al. (2009). Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat. Genet. 41, 1350-1353.
19. Eiraku, M., Takata, N., Ishibashi, H., Kawada, M., Sakakura, E., Okuda, S., Sekiguchi, K., Adachi, T. and Sasai, Y. (2011). Self-organizing optic-cup morphogenesis in three-dimensional culture. Nature 472, 51-56.
20. Friedman, D. S., O'Colmain, B. J., Muñoz, B., Tomany, S. C., McCarty, C., de Jong, P. T. V. M., Nemesure, B., Mitchell, P., Kempen, J. and the Eye Diseases Prevalence Research Group (2004). Prevalence of age-related macular degeneration in the United States. Arch. Ophthalmol. 122, 564-572.
21. Fusaki, N., Ban, H., Nishiyama, A., Saeki, K. and Hasegawa, M. (2009). Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 85, 348-362.
22. Gal, A., Li, Y., Thompson, D. A., Weir, J., Orth, U., Jacobson, S. G., Apfelstedt-Sylla, E. and Vollrath, D. (2000). Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa. Nat. Genet. 26, 270-271.
23. Garita-Hernández, M., Diaz-Corrales, F., Lukovic, D., Guede, I. G., Lloret, A. D., Sánchez, M. L. V., Massalini, S., Erceg, S. and Bhattacharya, S. S. (2013). Hypoxia increases the yield of photoreceptors differentiating from mouse embryonic stem cells and improves the modeling of retinogenesis in vitro. Stem Cells 31, 966-978.
24. Giansanti, F., Eandi, C. M. and Virgili, G. (2009). Macular translocation for neovascular age-related macular degeneration. Cochrane Database Syst. Rev. 4, CD006928.
25. Gore, A., Li, Z., Fung, H.-L., Young, J. E., Agarwal, S., Antosiewicz-Bourget, J., Canto, I., Giorgetti, A., Israel, M. A., Kiskinis, E. et al. (2011). Somatic coding mutations in human induced pluripotent stem cells. Nature 471, 63-67.
26. Guha, P., Morgan, J. W., Mostoslavsky, G., Rodrigues, N. P. and Boyd, A. S. (2013). Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells. Cell Stem Cell 12, 407-412.
27. Haines, J. L., Hauser, M. A., Schmidt, S., Scott, W. K., Olson, L. M., Gallins, P., Spencer, K. L., Kwan, S. Y., Noureddine, M., Gilbert, J. R. et al. (2005). Complement factor H variant increases the risk of age-related macular degeneration. Science 308, 419-421.
28. Hamel, C. P., Jenkins, N. A., Gilbert, D. J., Copeland, N. G. and Redmond, T. M. (1994). The gene for the retinal pigment epithelium-specific protein RPE65 is localized to human 1p31 and mouse 3. Genomics 20, 509-512.
29. Hartong, D. T., Berson, E. L. and Dryja, T. P. (2006). Retinitis pigmentosa. Lancet 368, 1795-1809.
30. Haruta, M., Sasai, Y., Kawasaki, H., Amemiya, K., Ooto, S., Kitada, M., Suemori, H., Nakatsuji, N., Ide, C., Honda, Y. et al. (2004). In vitro and in vivo characterization of pigment epithelial cells differentiated from primate embryonic stem cells. Invest. Ophthalmol. Vis. Sci. 45, 1020-1025.
31. Hirami, Y., Osakada, F., Takahashi, K., Okita, K., Yamanaka, S., Ikeda, H., Yoshimura, N. and Takahashi, M. (2009). Generation of retinal cells from mouse and human induced pluripotent stem cells. Neurosci. Lett. 458, 126-131.
32. Humayun, M. S., de Juan, E., Jr, del Cerro, M., Dagnelie, G., Radner, W., Sadda, S. R. and del Cerro, C. (2000). Human neural retinal transplantation. Invest. Ophthalmol. Vis. Sci. 41, 3100-3106.
33. Idelson, M., Alper, R., Obolensky, A., Ben-Shushan, E., Hemo, I., Yachimovich-Cohen, N., Khaner, H., Smith, Y., Wiser, O., Gropp, M. et al. (2009). Directed differentiation of human embryonic stem cells into functional retinal pigment epithelium cells. Cell Stem Cell 5, 396-408.
34. Ikeda, H., Osakada, F., Watanabe, K., Mizuseki, K., Haraguchi, T., Miyoshi, H., Kamiya, D., Honda, Y., Sasai, N., Yoshimura, N. et al. (2005). Generation of Rx+/Pax6+ neural retinal precursors from embryonic stem cells. Proc. Natl. Acad. Sci. USA 102, 11331-11336.
35. Jager, R. D., Mieler, W. F. and Miller, J. W. (2008). Age-related macular degeneration. N. Engl. J. Med. 358, 2606-2617.
36. Kim, D., Kim, C.-H., Moon, J.-I., Chung, Y.-G., Chang, M.-Y., Han, B.-S., Ko, S., Yang, E., Cha, K. Y., Lanza, R. et al. (2009). Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4, 472-476.
37. Klimanskaya, I., Hipp, J., Rezai, K. A., West, M., Atala, A. and Lanza, R. (2004). Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning Stem Cells 6, 217-245.
38. Kokkinaki, M., Sahibzada, N. and Golestaneh, N. (2011). Human induced pluripotent stem-derived retinal pigment epithelium (RPE) cells exhibit ion transport, membrane potential, polarized vascular endothelial growth factor secretion, and gene expression pattern similar to native RPE. Stem Cells 29, 825-835.
39. Kumar, A., Raj, M., Mochi, T. B., Mohanty, S., Seth, T. and Azad, R. (2012). Assessment of central retinal function after autologous bone marrow derived intravitreal stem cells injection in patients with retinitis pigmentosa using multifocal ERG: a pilot study. World J. Retina Vit. 2, 5-13.
40. Lamba, D. A., Karl, M. O., Ware, C. B. and Reh, T. A. (2006). Efficient generation of retinal progenitor cells from human embryonic stem cells. Proc. Natl. Acad. Sci. USA 103, 12769-12774.
41. Larijani, B., Esfahani, E. N., Amini, P., Nikbin, B., Alimoghaddam, K., Amiri, S., Malekzadeh, R., Yazdi, N. M., Ghodsi, M., Dowlati, Y. et al. (2012). Stem cell therapy in treatment of different diseases. Acta Med. Iran. 50, 79-96.
42. Li, Y., Reca, R. G., Atmaca-Sonmez, P., Ratajczak, M. Z., Ildstad, S. T., Kaplan, H. J. and Enzmann, V. (2006). Retinal pigment epithelium damage enhances expression of chemoattractants and migration of bone marrow-derived stem cells. Invest. Ophthalmol. Vis. Sci. 47, 1646-1652.
43. Li, M., Yu, A., Zhang, F., Dai, G., Cheng, H., Wang, X. and An, Y. (2012). Treatment of one case of cerebral palsy combined with posterior visual pathway injury using autologous bone marrow mesenchymal stem cells. J. Transl. Med. 10, 100.
44. Liao, J. L., Yu, J., Huang, K., Hu, J., Diemer, T., Ma, Z., Dvash, T., Yang, X. J., Travis, G. H., Williams, D. S. et al. (2010). Molecular signature of primary retinal pigment epithelium and stem-cell-derived RPE cells. Hum. Mol. Genet. 19, 4229-4238.
45. Lu, B., Malcuit, C., Wang, S., Girman, S., Francis, P., Lemieux, L., Lanza, R. and Lund, R. (2009). Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells 27, 2126-2135.
46. Lu, B., Wang, S., Girman, S., McGill, T., Ragaglia, V. and Lund, R. (2010). Human adult bone marrow-derived somatic cells rescue vision in a rodent model of retinal degeneration. Exp. Eye Res. 91, 449-455.
47. Lund, R. D., Wang, S., Klimanskaya, I., Holmes, T., Ramos-Kelsey, R., Lu, B., Girman, S., Bischoff, N., Sauvé, Y. and Lanza, R. (2006). Human embryonic stem cell-derived cells rescue visual function in dystrophic RCS rats. Cloning Stem Cells 8, 189-199.
48. Lund, R. D., Wang, S., Lu, B., Girman, S., Holmes, T., Sauvé, Y., Messina, D. J., Harris, I. R., Kihm, A. J., Harmon, A. M. et al. (2007). Cells isolated from umbilical cord tissue rescue photoreceptors and visual functions in a rodent model of retinal disease. Stem Cells 25, 602-611.
49. MacLaren, R. E., Pearson, R. A., MacNeil, A., Douglas, R. H., Salt, T. E., Akimoto, M., Swaroop, A., Sowden, J. C. and Ali, R. R. (2006). Retinal repair by transplantation of photoreceptor precursors. Nature 444, 203-207.
50. Martin, D. F., Maguire, M. G., Ying, G. S., Grunwald, J. E., Fine, S. L. and Jaffe, G. J. (2011). Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 364, 1897-1908.
51. McGill, T. J., Cottam, B., Lu, B., Wang, S., Girman, S., Tian, C., Huhn, S. L., Lund, R. D. and Capela, A. (2012). Transplantation of human central nervous system stem cells - neuroprotection in retinal degeneration. Eur. J. Neurosci. 35, 468-477.
52. Medeiros, N. E. and Curcio, C. A. (2001). Preservation of ganglion cell layer neurons in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 42, 795-803.
53. Mellough, C. B., Sernagor, E., Moreno-Gimeno, I., Steel, D. H. W. and Lako, M. (2012). Efficient stage-specific differentiation of human pluripotent stem cells toward retinal photoreceptor cells. Stem Cells 30, 673-686.
54. Meyer, J. S., Shearer, R. L., Capowski, E. E., Wright, L. S., Wallace, K. A., McMillan, E. L., Zhang, S.-C. and Gamm, D. M. (2009). Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc. Natl. Acad. Sci. USA 106, 16698-16703.
55. Meyer, J. S., Howden, S. E., Wallace, K. A., Verhoeven, A. D., Wright, L. S., Capowski, E. E., Pinilla, I., Martin, J. M., Tian, S., Stewart, R. et al. (2011). Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment. Stem Cells 29, 1206-1218.
56. Nakano, T., Ando, S., Takata, N., Kawada, M., Muguruma, K., Sekiguchi, K., Saito, K., Yonemura, S., Eiraku, M. and Sasai, Y. (2012). Self-formation of optic cups and storable stratified neural retina from human ESCs. Cell Stem Cell 10, 771-785.
57. Osakada, F., Jin, Z.-B., Hirami, Y., Ikeda, H., Danjyo, T., Watanabe, K., Sasai, Y. and Takahashi, M. (2009). In vitro differentiation of retinal cells from human pluripotent stem cells by small-molecule induction. J. Cell Sci. 122, 3169-3179.
58. Otani, A., Dorrell, M. I., Kinder, K., Moreno, S. K., Nusinowitz, S., Banin, E., Heckenlively, J. and Friedlander, M. (2004). Rescue of retinal degeneration by intravitreally injected adult bone marrow-derived lineage-negative hematopoietic stem cells. J. Clin. Invest. 114, 765-774.
59. Owen, C. G., Jarrar, Z., Wormald, R., Cook, D. G., Fletcher, A. E. and Rudnicka, A. R. (2012). The estimated prevalence and incidence of late stage age related macular degeneration in the UK. Br. J. Ophthalmol. 96, 752-756.
60. Pappa, K. I. and Anagnou, N. P. (2009). Novel sources of fetal stem cells: where do they fit on the developmental continuum? Regen. Med. 4, 423-433.
61. Park, S. S., Caballero, S., Bauer, G., Shibata, B., Roth, A., Fitzgerald, P. G., Forward, K. I., Zhou, P., McGee, J., Telander, D. G. et al. (2012). Long-term effects of intravitreal injection of GMP-grade bone-marrow-derived CD34+ cells in NOD-SCID mice with acute ischemia-reperfusion injury. Invest. Ophthalmol. Vis. Sci. 53, 986-994.
62. Pearson, R. A., Barber, A. C., Rizzi, M., Hippert, C., Xue, T., West, E. L., Duran, Y., Smith, A. J., Chuang, J. Z., Azam, S. A. et al. (2012). Restoration of vision after transplantation of photoreceptors. Nature 485, 99-103.
63. Radtke, N. D., Aramant, R. B., Seiler, M. J., Petry, H. M. and Pidwell, D. (2004). Vision change after sheet transplant of fetal retina with retinal pigment epithelium to a patient with retinitis pigmentosa. Arch. Ophthalmol. 122, 1159-1165.
64. Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y. and Kim, R. Y. (2006). Ranibizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 355, 1419-1431.
65. Salero, E., Blenkinsop, T. A., Corneo, B., Harris, A., Rabin, D., Stern, J. H. and Temple, S. (2012). Adult human RPE can be activated into a multipotent stem cell that produces mesenchymal derivatives. Cell Stem Cell 10, 88-95.
66. Sauvé, Y., Girman, S. V., Wang, S., Keegan, D. J. and Lund, R. D. (2002). Preservation of visual responsiveness in the superior colliculus of RCS rats after retinal pigment epithelium cell transplantation. Neuroscience 114, 389-401.
67. Schwartz, S. D., Hubschman, J.-P., Heilwell, G., Franco-Cardenas, V., Pan, C. K., Ostrick, R. M., Mickunas, E., Gay, R., Klimanskaya, I. and Lanza, R. (2012). Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 379, 713-720.
68. Singhal, S., Bhatia, B., Jayaram, H., Becker, S., Jones, M. F., Cottrill, P. B., Khaw, P. T., Salt, T. E. and Limb, G. A. (2012). Human Müller glia with stem cell characteristics differentiate into retinal ganglion cell (RGC) precursors in vitro and partially restore RGC function in vivo following transplantation. Stem Cells Transl. Med. 1, 188-199.
69. Siqueira, R. C., Messias, A., Voltarelli, J. C., Scott, I. U. and Jorge, R. (2011). Intravitreal injection of autologous bone marrow-derived mononuclear cells for hereditary retinal dystrophy: a phase I trial. Retina 31, 1207-1214.
70. Sparrow, J. R., Hicks, D. and Hamel, C. P. (2010). The retinal pigment epithelium in health and disease. Curr. Mol. Med. 10, 802-823.
71. Strauss, O. (2005). The retinal pigment epithelium in visual function. Physiol. Rev. 85, 845-881.
72. Takahashi, K. and Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676.
73. Tezel, T. H., Del Priore, L. V. and Kaplan, H. J. (2004). Reengineering of aged Bruch's membrane to enhance retinal pigment epithelium repopulation. Invest. Ophthalmol. Vis. Sci. 45, 3337-3348.
74. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S. and Jones, J. M. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147.
75. Tsukahara, I., Ninomiya, S., Castellarin, A., Yagi, F., Sugino, I. K. and Zarbin, M. A. (2002). Early attachment of uncultured retinal pigment epithelium from aged donors onto Bruch's membrane explants. Exp. Eye Res. 74, 255-266.
76. van Zeeburg, E. J. T., Maaijwee, K. J. M., Missotten, T. O. A. R., Heimann, H. and van Meurs, J. C. (2012). A free retinal pigment epithelium-choroid graft in patients with exudative age-related macular degeneration: results up to 7 years. Am. J. Ophthalmol. 153, 120-127.e2.
77. Vugler, A., Carr, A.-J., Lawrence, J., Chen, L. L., Burrell, K., Wright, A., Lundh, P., Semo, M., Ahmado, A., Gias, C. et al. (2008). Elucidating the phenomenon of HESC-derived RPE: anatomy of cell genesis, expansion and retinal transplantation. Exp. Neurol. 214, 347-361.
78. Walia, S. and Fishman, G. A. (2009). Natural history of phenotypic changes in Stargardt macular dystrophy. Ophthalmic Genet. 30, 63-68.
79. Warren, L., Manos, P. D., Ahfeldt, T., Loh, Y.-H., Li, H., Lau, F., Ebina, W., Mandal, P. K., Smith, Z. D., Meissner, A. et al. (2010). Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7, 618-630.
80. Yang, Z., Chen, Y., Lillo, C., Chien, J., Yu, Z., Michaelides, M., Klein, M., Howes, K. A., Li, Y., Kaminoh, Y. et al. (2008). Mutant prominin 1 found in patients with macular degeneration disrupts photoreceptor disk morphogenesis in mice. J. Clin. Invest. 118, 2908-2916.
81. Ying, Q.-L., Nichols, J., Evans, E. P. and Smith, A. G. (2002). Changing potency by spontaneous fusion. Nature 416, 545-548.
82. Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R. et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920.
83. Zhang, K., Kniazeva, M., Han, M., Li, W., Yu, Z., Yang, Z., Li, Y., Metzker, M. L., Allikmets, R., Zack, D. J. et al. (2001). A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy. Nat. Genet. 27, 151-152.
84. Zhao, T., Zhang, Z.-N., Rong, Z. and Xu, Y. (2011). Immunogenicity of induced pluripotent stem cells. Nature 474, 212-215.
85. Zhu, D., Deng, X., Spee, C., Sonoda, S., Hsieh, C. L., Barron, E., Pera, M. and Hinton, D. R. (2011). Polarized secretion of PEDF from human embryonic stem cell-derived RPE promotes retinal progenitor cell survival. Invest. Ophthalmol. Vis. Sci. 52, 1573-1585.
86. Zimmermann, A., Preynat-Seauve, O., Tiercy, J.-M., Krause, K.-H. and Villard, J. (2012). Haplotype-based banking of human pluripotent stem cells for transplantation: potential and limitations. Stem Cells Dev. 21, 2364-2373.